DAVID F HALE Insider Trading $HSTO Histogen Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DAVID F HALE.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DAVID F HALE. DAVID F HALE is Director in MICROMET, INC. ($MITI) and President and CEO in MICROMET, INC. ($MITI) and Chairman in BIOCEPT INC ($BIOC) and Director in BIOCEPT INC ($BIOC) and Director in SANTARUS INC ($SNTS) and Director in GTX INC /DE/ ($GTXI) and Director in METABASIS THERAPEUTICS INC ($MBRX) and Director in Pernix Sleep, Inc. ($SOMX) and Director in Conatus Pharmaceuticals Inc. ($CNAT).

DAVID F HALE in Histogen Inc.

Trading Symbol: HSTO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID F HALE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 01 2019
$HSTO Market Capitalization: $127.38M
$HSTO Previous Close: $5.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of DAVID F HALE in Histogen Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BIOC, HSTO, MBRX, MITI, ONCT, SOMX, SNTS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Jul 01 2019	CNAT	Conatus Pharmaceut ...	HALE DAVID F	Director	Option Exercise	A	0.29	45,000	13,050	45,000
Jun 25 2018	CNAT	Conatus Pharmaceut ...	HALE DAVID F	Director	Option Exercise	A	4.99	45,000	224,550	45,000
Jun 26 2017	CNAT	Conatus Pharmaceut ...	HALE DAVID F	Director	Option Exercise	A	4.96	45,000	223,200	45,000
Jun 24 2016	CNAT	Conatus Pharmaceut ...	HALE DAVID F	Director	Option Exercise	A	2.13	45,000	95,850	45,000
Jun 15 2015	CNAT	Conatus Pharmaceut ...	HALE DAVID F	Director	Option Exercise	A	5.52	35,000	193,200	35,000

Page: 1